Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lupus Erythematosus, Systemic | 5 | 2022 | 2099 | 0.860 |
Why?
|
Health Priorities | 2 | 2015 | 379 | 0.780 |
Why?
|
Rheumatology | 1 | 2022 | 576 | 0.560 |
Why?
|
Attitude to Health | 2 | 2014 | 2051 | 0.500 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2575 | 0.370 |
Why?
|
Decision Making | 2 | 2015 | 3869 | 0.370 |
Why?
|
Macrophage Activation Syndrome | 2 | 2022 | 111 | 0.360 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2022 | 4248 | 0.320 |
Why?
|
Patient Preference | 1 | 2014 | 886 | 0.290 |
Why?
|
Primary Prevention | 1 | 2014 | 1166 | 0.290 |
Why?
|
Choice Behavior | 1 | 2012 | 802 | 0.290 |
Why?
|
Pediatrics | 1 | 2021 | 3462 | 0.280 |
Why?
|
Geriatric Assessment | 1 | 2013 | 1369 | 0.270 |
Why?
|
Longevity | 1 | 2013 | 1069 | 0.260 |
Why?
|
Connecticut | 2 | 2014 | 363 | 0.230 |
Why?
|
Terminal Care | 1 | 2015 | 1688 | 0.230 |
Why?
|
Synovial Fluid | 1 | 2021 | 394 | 0.170 |
Why?
|
Eosinophilia | 1 | 2023 | 531 | 0.160 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2022 | 256 | 0.160 |
Why?
|
Cell Polarity | 1 | 2021 | 644 | 0.160 |
Why?
|
Adenosine Deaminase | 1 | 2019 | 241 | 0.150 |
Why?
|
Focus Groups | 1 | 2021 | 1320 | 0.140 |
Why?
|
Quality of Life | 3 | 2017 | 12730 | 0.140 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 609 | 0.140 |
Why?
|
Drug Approval | 1 | 2022 | 740 | 0.130 |
Why?
|
Biological Products | 1 | 2023 | 856 | 0.120 |
Why?
|
Th17 Cells | 1 | 2020 | 765 | 0.110 |
Why?
|
Myocardial Infarction | 1 | 2014 | 11690 | 0.110 |
Why?
|
Lung Diseases | 1 | 2023 | 1884 | 0.110 |
Why?
|
Qualitative Research | 1 | 2021 | 2680 | 0.110 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2019 | 1675 | 0.100 |
Why?
|
Child | 8 | 2023 | 77478 | 0.100 |
Why?
|
Writing | 1 | 2012 | 205 | 0.090 |
Why?
|
Disability Evaluation | 1 | 2017 | 1827 | 0.090 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2021 | 2986 | 0.090 |
Why?
|
Medication Adherence | 1 | 2021 | 2055 | 0.090 |
Why?
|
Chronic Disease | 2 | 2015 | 9144 | 0.090 |
Why?
|
Medicaid | 1 | 2022 | 2716 | 0.080 |
Why?
|
Adolescent | 6 | 2022 | 85649 | 0.080 |
Why?
|
Aged | 5 | 2022 | 162944 | 0.080 |
Why?
|
Humans | 17 | 2023 | 742088 | 0.080 |
Why?
|
Registries | 2 | 2021 | 8077 | 0.080 |
Why?
|
Pain Measurement | 1 | 2017 | 3418 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3695 | 0.070 |
Why?
|
Adult | 6 | 2022 | 213712 | 0.070 |
Why?
|
Stress, Psychological | 1 | 2021 | 4229 | 0.070 |
Why?
|
Smoking | 1 | 2022 | 8969 | 0.070 |
Why?
|
Young Adult | 2 | 2022 | 56350 | 0.070 |
Why?
|
Patient Participation | 1 | 2014 | 1445 | 0.060 |
Why?
|
Male | 9 | 2021 | 349538 | 0.060 |
Why?
|
Psychometrics | 1 | 2013 | 2999 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10163 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14720 | 0.060 |
Why?
|
Female | 8 | 2021 | 379592 | 0.050 |
Why?
|
Risk Factors | 3 | 2023 | 72145 | 0.050 |
Why?
|
Obesity | 1 | 2022 | 12705 | 0.040 |
Why?
|
Chemokine CXCL9 | 1 | 2019 | 132 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2023 | 1262 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3766 | 0.040 |
Why?
|
Blood Sedimentation | 1 | 2019 | 231 | 0.040 |
Why?
|
Comorbidity | 1 | 2013 | 10372 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15056 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2019 | 248 | 0.040 |
Why?
|
Middle Aged | 2 | 2022 | 213127 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2023 | 986 | 0.040 |
Why?
|
Dermatomyositis | 1 | 2019 | 223 | 0.040 |
Why?
|
United States | 2 | 2022 | 69693 | 0.040 |
Why?
|
Ferritins | 1 | 2019 | 590 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2021 | 1866 | 0.040 |
Why?
|
Th1 Cells | 1 | 2021 | 1056 | 0.030 |
Why?
|
Physical Examination | 1 | 2022 | 1239 | 0.030 |
Why?
|
Cohort Studies | 2 | 2017 | 40450 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2013 | 19862 | 0.030 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 546 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2036 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 24913 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2011 | 0.030 |
Why?
|
Canada | 1 | 2017 | 2061 | 0.030 |
Why?
|
Reference Values | 1 | 2019 | 4982 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3510 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3266 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2023 | 4664 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4379 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2013 | 57683 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 40955 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4438 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4282 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13921 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3740 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 20928 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2023 | 77098 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12242 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21719 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10578 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13403 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 17400 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15530 | 0.010 |
Why?
|
Infant | 1 | 2021 | 35070 | 0.010 |
Why?
|
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_